MedTrace Logo

89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors

NCT03638804 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-12-05

No results posted yet for this study

Summary

This is a single arm study by using 89Zr-labeled KN035 (89Zr-KN035) PET imaging to evaluate the biodistribution and target lesion uptake of 89Zr-KN035 in patients with PD-L1 positive advanced solid tumors.

Conditions

  • Solid Tumor, Adult

Interventions

DIAGNOSTIC_TEST

89Zr-KN035

Single injection of 89Zr labeled KN035 in subjects to observe KN035 affinity in PD-L1 expressed Solid tumors by using PET imaging.

Sponsors & Collaborators

  • MITRO Biotech Co., Ltd.

    collaborator UNKNOWN

  • The First Affiliated Hospital of Soochow University

    lead OTHER

Principal Investigators

  • Liyan Miao, PhD · The First Affiliated Hospital of Soochow University

  • Jianan Huang, PhD · The First Affiliated Hospital of Soochow University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-12
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03638804 on ClinicalTrials.gov